244 related articles for article (PubMed ID: 12816539)
1. Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
Sarno S; de Moliner E; Ruzzene M; Pagano MA; Battistutta R; Bain J; Fabbro D; Schoepfer J; Elliott M; Furet P; Meggio F; Zanotti G; Pinna LA
Biochem J; 2003 Sep; 374(Pt 3):639-46. PubMed ID: 12816539
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking.
Vangrevelinghe E; Zimmermann K; Schoepfer J; Portmann R; Fabbro D; Furet P
J Med Chem; 2003 Jun; 46(13):2656-62. PubMed ID: 12801229
[TBL] [Abstract][Full Text] [Related]
3. The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin.
Raaf J; Klopffleisch K; Issinger OG; Niefind K
J Mol Biol; 2008 Mar; 377(1):1-8. PubMed ID: 18242640
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study.
Meggio F; Pagano MA; Moro S; Zagotto G; Ruzzene M; Sarno S; Cozza G; Bain J; Elliott M; Deana AD; Brunati AM; Pinna LA
Biochemistry; 2004 Oct; 43(40):12931-6. PubMed ID: 15461466
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the catalytic subunit of protein kinase CK2 from Zea mays at 2.1 A resolution.
Niefind K; Guerra B; Pinna LA; Issinger OG; Schomburg D
EMBO J; 1998 May; 17(9):2451-62. PubMed ID: 9564028
[TBL] [Abstract][Full Text] [Related]
6. Inclining the purine base binding plane in protein kinase CK2 by exchanging the flanking side-chains generates a preference for ATP as a cosubstrate.
Yde CW; Ermakova I; Issinger OG; Niefind K
J Mol Biol; 2005 Mar; 347(2):399-414. PubMed ID: 15740749
[TBL] [Abstract][Full Text] [Related]
7. 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.
Pagano MA; Meggio F; Ruzzene M; Andrzejewska M; Kazimierczuk Z; Pinna LA
Biochem Biophys Res Commun; 2004 Sep; 321(4):1040-4. PubMed ID: 15358133
[TBL] [Abstract][Full Text] [Related]
8. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA
J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294
[TBL] [Abstract][Full Text] [Related]
9. Catalytic activity of mutants of yeast protein kinase CK2alpha.
Sajnaga E; Kubiński K; Szyszka R
Acta Biochim Pol; 2008; 55(4):767-76. PubMed ID: 19015772
[TBL] [Abstract][Full Text] [Related]
10. Development and exploitation of CK2 inhibitors.
Sarno S; Ruzzene M; Frascella P; Pagano MA; Meggio F; Zambon A; Mazzorana M; Di Maira G; Lucchini V; Pinna LA
Mol Cell Biochem; 2005 Jun; 274(1-2):69-76. PubMed ID: 16335530
[TBL] [Abstract][Full Text] [Related]
11. GTP plus water mimic ATP in the active site of protein kinase CK2.
Niefind K; Pütter M; Guerra B; Issinger OG; Schomburg D
Nat Struct Biol; 1999 Dec; 6(12):1100-3. PubMed ID: 10581548
[TBL] [Abstract][Full Text] [Related]
12. First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2.
Raaf J; Issinger OG; Niefind K
J Mol Biol; 2009 Mar; 386(5):1212-21. PubMed ID: 19361447
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effect and kinetic analysis of sodium quercetin-7,4'-disulphate on recombinant human protein kinase CK2 holoenzyme].
Liu XG; Liang NC; Liu W; She J; Mo LE
Yao Xue Xue Bao; 2002 Mar; 37(3):165-8. PubMed ID: 12579753
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effect of AG1109 on recombinant human protein kinase CK2 holoenzyme].
Liu XG; Liang NC
Ai Zheng; 2002 Feb; 21(2):153-7. PubMed ID: 12479065
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect and its kinetic analysis of tyrphostin AG1478 on recombinant human protein kinase CK2 holoenzyme.
Liu XG; Liang NC
Acta Pharmacol Sin; 2002 Jun; 23(6):556-61. PubMed ID: 12060532
[TBL] [Abstract][Full Text] [Related]
16. Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationships.
Chilin A; Battistutta R; Bortolato A; Cozza G; Zanatta S; Poletto G; Mazzorana M; Zagotto G; Uriarte E; Guiotto A; Pinna LA; Meggio F; Moro S
J Med Chem; 2008 Feb; 51(4):752-9. PubMed ID: 18251491
[TBL] [Abstract][Full Text] [Related]
17. Eukaryotic translation-initiation factor eIF2beta binds to protein kinase CK2: effects on CK2alpha activity.
Llorens F; Roher N; Miró FA; Sarno S; Ruiz FX; Meggio F; Plana M; Pinna LA; Itarte E
Biochem J; 2003 Nov; 375(Pt 3):623-31. PubMed ID: 12901717
[TBL] [Abstract][Full Text] [Related]
18. Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
Sekiguchi Y; Nakaniwa T; Kinoshita T; Nakanishi I; Kitaura K; Hirasawa A; Tsujimoto G; Tada T
Bioorg Med Chem Lett; 2009 Jun; 19(11):2920-3. PubMed ID: 19414254
[TBL] [Abstract][Full Text] [Related]
19. The raison d'être of constitutively active protein kinases: the lesson of CK2.
Pinna LA
Acc Chem Res; 2003 Jun; 36(6):378-84. PubMed ID: 12809523
[TBL] [Abstract][Full Text] [Related]
20. Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole.
Battistutta R; De Moliner E; Sarno S; Zanotti G; Pinna LA
Protein Sci; 2001 Nov; 10(11):2200-6. PubMed ID: 11604527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]